Multiomics Analysis Reveals Cuproptosis-Related Signature for Evaluating Prognosis and Immunotherapy Efficacy in Colorectal Cancer

HOXC6 impacts epithelial-mesenchymal transition and the immune microenvironment through gene transcription in gliomas

(2022) Hui Huang et al.   Cancer Cell International

Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer

(2022) Afsheen Raza et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Copper induces cell death by targeting lipoylated TCA cycle proteins

(2022) Peter Tsvetkov et al.   SCIENCE

A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma

(2022) Xiaocong Mo et al.   Frontiers in Oncology

Efficacy and safety of anti-PD-1/PD-L1 therapy in the treatment of advanced colorectal cancer: a meta-analysis

(2022) Yuegang Li et al.   BMC GASTROENTEROLOGY

ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer

(2022) Dilara Akhoundova et al.   INTERNATIONAL JOURNAL OF CANCER

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy

(2022) Peijie Zheng et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma

(2022) Cheng Yan et al.   Journal of Translational Medicine

DNA methylation analysis of normal colon organoids from familial adenomatous polyposis patients reveals novel insight into colon cancer development

(2022) Matthew A. Devall et al.   Clinical Epigenetics

Prognostic value of cuproptosis-related genes signature and its impact on the reshaped immune microenvironment of glioma

(2022) Siliang Chen et al.   Frontiers in Pharmacology

Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma

(2022) Bao Wang et al.   Frontiers in Immunology

Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma

(2022) Tianhao Cong et al.   Frontiers in Genetics

Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma

(2022) Aibin Liu et al.   Frontiers in Genetics

A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma

(2022) Shouzheng Ma et al.   Translational Lung Cancer Research

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation

(2021) Zaina T. Al-Salama   DRUGS

Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial

(2021) Thierry Andre et al.   LANCET ONCOLOGY

Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A

(2021) Wei Gao et al.   Molecular Oncology

Enhanced G1 arrest and apoptosis via MDM4/MDM2 double knockdown and MEK inhibition in wild‑type TP53 colon and gastric cancer cells with aberrant KRAS signaling

(2021) Xiaoxuan Wang et al.   Oncology Letters

SphK1‐driven autophagy potentiates focal adhesion paxillin‐mediated metastasis in colorectal cancer

(2021) Jiang‐Ni Wu et al.   Cancer Medicine

Effects of YAP1 and SFRP2 overexpression on the biological behavior of colorectal cancer cells and their molecular mechanisms

(2021) Zhenzhen Bai et al.   Journal of Gastrointestinal Oncology

Upfront progression under pembrolizumab followed by a complete response after encorafenib and cetuximab treatment in BRAF V600E ‐mutated and microsatellite unstable metastatic colorectal cancer patient: A case report

(2021) Claire Gallois et al.   GENES CHROMOSOMES & CANCER

Apoptosis, Pyroptosis, and Necroptosis—Oh My! The Many Ways a Cell Can Die

(2021) Natália Ketelut-Carneiro et al.   JOURNAL OF MOLECULAR BIOLOGY

Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination

(2020) Marco Montagner et al.   NATURE CELL BIOLOGY

The Therapeutic Potential of MEK1/2 inhibitors in the treatment of gynecological cancers: Rational Strategies and Recent Progress.

(2020) Sadaf Ghanaatgar-Kasbi et al.   CURRENT CANCER DRUG TARGETS

Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer

(2020) Eric X. Chen et al.   JAMA Oncology

Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade

(2020) Alessandra Rossi et al.   Cells

Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism?

(2020) Marina Serra et al.   Frontiers in Oncology

Copper homeostasis: Emerging target for cancer treatment

(2020) Yueqin Li   IUBMB LIFE

Impact of high tumor mutational burden in solid tumors and challenges for biomarker application

(2020) Mairéad G. McNamara et al.   CANCER TREATMENT REVIEWS

Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis

(2020) Lang Rao et al.   Nature Communications

Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer

(2020) Ana Oaknin et al.   JAMA Oncology

Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

(2020) Masanori Oshi et al.   Cancers

Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside

(2020) Darleny Y. Lizardo et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Tumour–stroma ratio has poor prognostic value in non-pedunculated T1 colorectal cancer: A multi-centre case-cohort study

(2020) Hao Dang et al.   United European Gastroenterology Journal

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

(2019) Robert M. Samstein et al.   NATURE GENETICS

Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage

(2019) Dvir Aran et al.   NATURE IMMUNOLOGY

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-mutant Pancreatic and Colorectal Cancer

(2019) Jörn Weisner et al.   CANCER RESEARCH

MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer

(2019) Tianzuo Zhan et al.   Nature Communications

TNNT1, a prognostic indicator in colon adenocarcinoma, regulates cell behaviors and mediates EMT process

(2019) Yun-He Hao et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis

(2019) Rene Jackstadt et al.   CANCER CELL

A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting

(2019) Laleh Sharifi et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

TNNT1, negatively regulated by miR‐873, promotes the progression of colorectal cancer

(2019) Yu Chen et al.   JOURNAL OF GENE MEDICINE

Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment

(2018) Ganjun Yu et al.   Cellular & Molecular Immunology

Efficacy of the MEK Inhibitor Cobimetinib and its Potential Application to Colorectal Cancer Cells

(2018) Shu Gong et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

TNNT1 facilitates proliferation of breast cancer cells by promoting G 1 /S phase transition

(2018) Yawei Shi et al.   LIFE SCIENCES

Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap

(2018) Wantong Song et al.   Nature Communications

Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism

(2018) Huensuk Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer

(2018) Neda Yaghoubi et al.   BIOMEDICINE & PHARMACOTHERAPY

Schedule-dependent synergistic effects of 5-fluorouracil and selumetinib in KRAS or BRAF mutant colon cancer models

(2018) Hye Yeon Jang et al.   BIOCHEMICAL PHARMACOLOGY

Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid–upper rectal cancer

(2017) Seo Hee Choi et al.   JOURNAL OF RADIATION RESEARCH

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

(2017) Pornpimol Charoentong et al.   Cell Reports

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

(2017) Zachary R. Chalmers et al.   Genome Medicine

Effect of Modified Vaccinia Ankara–5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer

(2017) Martin Scurr et al.   JAMA Oncology

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

(2016) Amanpreet Kaur et al.   NATURE

Hes4: A potential prognostic biomarker for newly diagnosed patients with high-grade osteosarcoma

(2016) Madonna McManus et al.   PEDIATRIC BLOOD & CANCER

Silencing homeobox C6 inhibits colorectal cancer cell proliferation

(2016) Meiling Ji et al.   Oncotarget

Methylation of SFRP2 gene as a promising noninvasive biomarker using feces in colorectal cancer diagnosis: a systematic meta-analysis

(2016) Qihua Yang et al.   Scientific Reports

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance

(2015) Niels F. Jensen et al.   Molecular Oncology

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS

Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium

(2015) Kate Lawrenson et al.   PLoS One

Copper is required for oncogenic BRAF signalling and tumorigenesis

(2014) Donita C. Brady et al.   NATURE

Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma

(2014) A. Stoeck et al.   Cancer Discovery

The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints

(2014) Nicolas J. Llosa et al.   Cancer Discovery

Crizotinib Induces PUMA-Dependent Apoptosis in Colon Cancer Cells

(2013) X. Zheng et al.   MOLECULAR CANCER THERAPEUTICS

Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy

(2013) Reiko Nishihara et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inferring tumour purity and stromal and immune cell admixture from expression data

(2013) Kosuke Yoshihara et al.   Nature Communications

The sva package for removing batch effects and other unwanted variation in high-throughput experiments

(2012) Jeffrey T. Leek et al.   BIOINFORMATICS

Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant Chemotherapy Trials

(2011) Frank A. Sinicrope et al.   JOURNAL OF CLINICAL ONCOLOGY

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

(2010) Matthew D. Wilkerson et al.   BIOINFORMATICS

CellMiner: a relational database and query tool for the NCI-60 cancer cell lines

(2009) Uma T Shankavaram et al.   BMC GENOMICS